학술논문
Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life
Document Type
Article
Author
Source
In ESMO Open August 2022 7(4)
Subject
Language
ISSN
2059-7029